News

Flow Space on MSN6h
What the Latest GLP-1 Guidelines Could Mean for Midlife Women
In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) ...
The Cardiology Advisor7h
Compounded GLP-1 RAs May Elevate Risk for Adverse Events
Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.
Healthline13h
GLP-1 Weight Loss Results Not as Effective in Everyday Life, Study Finds
A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...
BMJ2d
Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very ...
Thus, both physical activity and GLP-1 RA treatment seem to facilitate weight loss maintenance, improve metabolic health and reduce systemic inflammation. However, diet-induced weight loss decreases ...
Business Wire3d
IFF Unveils Game-Changing Outlook on GLP-1 Consumers
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in food, beverage, and health and wellness, has released a new report highlighting how the rapidly growing GLP-1 consumer market is ...
The Lancet6d
Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial
aCancer and Medicine, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark bStatistics and Data Analysis, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark ...